In addition to promote the growth of stem cells in glioma, the BMAL1/CLOCK complex could also recruit immunosuppressive microglia to the TME, thereby establishing conditions associated with poorer prognoses [64]. The gene discussed is BMAL1; the disease is central nervous system cancer.